Maury Raycroft
Stock Analyst at Jefferies
(4.44)
# 1,186
Out of 4,683 analysts
235
Total ratings
44%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintained: Buy | $47 → $10 | $2.24 | +346.43% | 2 | Aug 6, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $44 → $42 | $26.69 | +57.36% | 7 | Aug 5, 2026 | |
| KPTI Karyopharm Therapeutics | Maintained: Buy | $35 → $11 | $1.92 | +472.92% | 7 | Jul 31, 2026 | |
| ERAS Erasca | Rated: Buy | $21 → $24 | $17.76 | +35.14% | 3 | Jul 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $39 → $47 | $49.65 | -5.34% | 3 | Jul 13, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $27 → $60 | $24.77 | +142.23% | 3 | Jun 26, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $132 | $112.11 | +17.74% | 6 | Jun 15, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $53 → $33 | $11.31 | +191.78% | 7 | May 12, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 | $4.39 | +173.35% | 1 | Apr 30, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $8 → $9 | $2.53 | +255.73% | 4 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $52 | $42.48 | +22.41% | 2 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 → $56 | $39.46 | +41.92% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $6.78 | +121.24% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $1.87 | +1,397.33% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $5.01 | +299.20% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $16.75 | +25.37% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.49 | +7.38% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $549 | $240.08 | +128.67% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $9.83 | +52.59% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $31.03 | +32.13% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $67.01 | -47.77% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $79 | $92.27 | n/a | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $23 | $13.83 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $1.02 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $6.20 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $3.71 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $15 | $9.89 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $1.5 | $0.1489 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.2816 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.21 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $129 | $26.46 | n/a | 14 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $0.000001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $26.76 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.11 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $35.28 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $88.88 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $60.90 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $0.7202 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $109 | $13.51 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $25 | $9.84 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $86 | $26.17 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $8.54 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $60.42 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $6.21 | n/a | 2 | May 22, 2018 |
Black Diamond Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $47 → $10
Current: $2.24
Upside: +346.43%
Tyra Biosciences
Aug 5, 2026
Maintained: Buy
Price Target: $44 → $42
Current: $26.69
Upside: +57.36%
Karyopharm Therapeutics
Jul 31, 2026
Maintained: Buy
Price Target: $35 → $11
Current: $1.92
Upside: +472.92%
Erasca
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $17.76
Upside: +35.14%
Hemab Therapeutics Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $39 → $47
Current: $49.65
Upside: -5.34%
Tango Therapeutics
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $24.77
Upside: +142.23%
Dianthus Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $132
Current: $112.11
Upside: +17.74%
Corbus Pharmaceuticals Holdings
May 12, 2026
Maintained: Buy
Price Target: $53 → $33
Current: $11.31
Upside: +191.78%
Bicycle Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $12
Current: $4.39
Upside: +173.35%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $2.53
Upside: +255.73%
Apr 5, 2026
Maintained: Buy
Price Target: $14 → $52
Current: $42.48
Upside: +22.41%
Mar 26, 2026
Rated: Buy
Price Target: $39 → $56
Current: $39.46
Upside: +41.92%
Mar 23, 2026
Maintained: Buy
Price Target: $14 → $15
Current: $6.78
Upside: +121.24%
Feb 25, 2026
Maintained: Buy
Price Target: $28
Current: $1.87
Upside: +1,397.33%
Dec 8, 2025
Maintained: Buy
Price Target: $15 → $20
Current: $5.01
Upside: +299.20%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $16.75
Upside: +25.37%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.49
Upside: +7.38%
Oct 30, 2025
Maintained: Buy
Price Target: $384 → $549
Current: $240.08
Upside: +128.67%
Oct 14, 2025
Maintained: Buy
Price Target: $14 → $15
Current: $9.83
Upside: +52.59%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $31.03
Upside: +32.13%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $67.01
Upside: -47.77%
Aug 15, 2025
Maintained: Buy
Price Target: $33 → $79
Current: $92.27
Upside: n/a
Aug 13, 2025
Maintained: Buy
Price Target: $40 → $23
Current: $13.83
Upside: n/a
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $1.02
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $8
Current: $6.20
Upside: n/a
May 19, 2025
Maintained: Buy
Price Target: $15 → $9
Current: $3.71
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $7 → $15
Current: $9.89
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $2 → $1.5
Current: $0.1489
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.2816
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: $21
Current: $1.21
Upside: n/a
Oct 4, 2024
Rated: Buy
Price Target: $129
Current: $26.46
Upside: n/a
Apr 4, 2024
Maintained: Buy
Price Target: $10 → $20
Current: $0.000001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $26.76
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $1.11
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $35.28
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $75
Current: $88.88
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $60.90
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $0.7202
Upside: n/a
Jun 22, 2021
Maintained: Buy
Price Target: $37 → $109
Current: $13.51
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $14 → $25
Current: $9.84
Upside: n/a
Jul 29, 2020
Maintained: Buy
Price Target: $34 → $86
Current: $26.17
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $25
Current: $8.54
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $60.42
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $6.21
Upside: n/a